In this review, the authors discuss the use of biomarkers as diagnostic tools for human primary membranous nephropathy. Learn more in this article from Biomarkers in Medicine.
Development and validation of an impedance biosensor for point-of-care detection of vascular cell adhesion molecule-1 toward lupus diagnostics
Learn more about the potential future application of point-of-care biosensors in clinical and at-home monitoring of autoimmune diseases, such as lupus in this article from Future Science OA
Researchers from the University of Illinois at Urbana-Champaign (IL, USA) have developed technology that could enable a smartphone to perform medical diagnostic tests.
Bioanalysis of Diagnostic and Therapeutic Oligonucleotides: An Emphasis on LC-FL and LC-MS Based Assays
In this article, recent developments and considerations for liquid chromatographic (LC) methods of oligonucleotides are discussed, highlighting LC-Mass Spectrometry and LC-Fluorescence assays, and the benefits of systematic incorporation into a bioanalysis laboratory.
In this editorial, the author discuss the growth in paper-based platforms, which have been ultilized in point-of-care in diease diagnostics such as cardiovascular disease.
Researchers have developed a diagnostic sensor, using a new heterogenous catalyst 16-sensor array system, that could detect disease with high specificity and sensitivity by analyzing exhaled breath.
PerkinElmer aims to expand their reach into the autoimmune and allergy diagnostic market through a $1.3 billion acquisition of EUROIMMUN.
Beckman Coulter showcase the Beckman Coulter Diagnostic Difference and a range of new products designed to provide comprehensive solutions for laboratory excellence.
Clinical trial results indicate that a new diagnostic patch could detect all severity levels of obstructive sleep apnea.
Bristol-Myers Squibb confirms equity investment in GeneCentric, company will examine the application of GeneCentric’s Cancer Subtyping Platform.